Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9,993 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase I-II trial of weekly bicalutamide in men with elevated prostate-specific antigen and negative prostate biopsies.
Zanardi S, Puntoni M, Maffezzini M, Bandelloni R, Mori M, Argusti A, Campodonico F, Turbino L, Branchi D, Montironi R, Decensi A. Zanardi S, et al. Among authors: mori m. Cancer Prev Res (Phila). 2009 Apr;2(4):377-84. doi: 10.1158/1940-6207.CAPR-08-0205. Epub 2009 Mar 31. Cancer Prev Res (Phila). 2009. PMID: 19336728 Free article. Clinical Trial.
A randomized, placebo-controlled, preoperative trial of allopurinol in subjects with colorectal adenoma.
Puntoni M, Branchi D, Argusti A, Zanardi S, Crosta C, Meroni E, Munizzi F, Michetti P, Coccia G, De Roberto G, Bandelloni R, Turbino L, Minetti E, Mori M, Salvi S, Boccardo S, Gatteschi B, Benelli R, Sonzogni A, DeCensi A. Puntoni M, et al. Among authors: mori m. Cancer Prev Res (Phila). 2013 Feb;6(2):74-81. doi: 10.1158/1940-6207.CAPR-12-0249. Epub 2012 Dec 4. Cancer Prev Res (Phila). 2013. PMID: 23213070 Clinical Trial.
KNTC1 introduces segmental heterogeneity to mitochondria.
Tsukamura A, Ariyama H, Hayashi N, Miyatake S, Okado S, Sultana S, Terakado I, Yamamoto T, Yamanaka S, Fujii S, Hamanoue H, Asano R, Mizushima T, Matsumoto N, Maruo Y, Mori M. Tsukamura A, et al. Among authors: mori m. Dis Model Mech. 2025 Jan 20:dmm.052063. doi: 10.1242/dmm.052063. Online ahead of print. Dis Model Mech. 2025. PMID: 39829138 Free article.
Multi-institutional Knowledge-Based (KB) plan prediction benchmark models for whole breast irradiation.
Tudda A, Castriconi R, Placidi L, Benecchi G, Buono RC, Cagni E, Cicchetti A, Landoni V, Malatesta T, Mazzilli A, Meffe G, Moretti E, Mori M, Oliviero C, Guidasci GR, Scaggion A, Trojani V, Vecchio AD, Fiorino C. Tudda A, et al. Among authors: mori m. Phys Med. 2025 Jan 16;130:104889. doi: 10.1016/j.ejmp.2024.104889. Online ahead of print. Phys Med. 2025. PMID: 39823915
Stage-specific efficacy of osimertinib in treatment-naïve EGFR-mutant non-small cell lung cancer according to baseline genetic alterations in circulating tumor DNA.
Taniguchi Y, Tamiya A, Osuga M, Isa SI, Nakamura K, Mizumori Y, Shinohara T, Yanai H, Nakatomi K, Oki M, Mori M, Kuwako T, Yamazaki K, Shimada M, Ando M, Koh Y. Taniguchi Y, et al. Among authors: mori m. Invest New Drugs. 2025 Jan 9. doi: 10.1007/s10637-024-01500-9. Online ahead of print. Invest New Drugs. 2025. PMID: 39789369
9,993 results